Pavani Chalasani, MD, MPH

Clinical and Translational Oncology Program co-Leader
Clinical and Translational Oncology Program


Dr. Chalasani completed her medical school at Gandhi Medical College in India, Internship, Residency and Fellowship in Hematology-Oncology at the University of Arizona. Dr. Chalasani is an Associate Professor of Medicine (Tenure) at the University of Arizona Cancer Center. She specializes in breast cancer and sees patients with breast cancer for treatment decisions regarding hormonal therapy (anti-estrogen therapy), chemotherapy, and second opinions. She is the Fellowship Program Director for University of Arizona Hematology-Oncology Fellowship Program.

Cancer Focus

Dr. Chalasani's primary clinical and research focus is on breast cancer. In addition to seeing patients in clinic, she is very active in research and has several ongoing translational and clinical projects. She leads the Breast Cancer Disease Oriented Team (DOT) and oversees Breast Cancer clinical research program. She has a translation laboratory which focuses on investigating and developing predictive and prognostic biomarkers. She is the Principal Investigator on several investigator-initiated trials, industry, and co-operative group protocols. She is the medical oncology study chair for NCI study in women with inflammatory breast cancer (S1706) and lead investigator for a randomized phase II trial in women with metastatic HER2+ breast cancer. She has received research funding from NIH/NCI, American Cancer Society, Better Than Ever and The University of Arizona Cancer Center-pilot funding mechanism.